🇺🇸 Coagulation Factor VIII in United States

488 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Haemorrhage — 150 reports (30.74%)
  2. Drug Ineffective — 111 reports (22.75%)
  3. Haemarthrosis — 45 reports (9.22%)
  4. Factor Viii Inhibition — 40 reports (8.2%)
  5. Dyspnoea — 26 reports (5.33%)
  6. Anaphylactic Reaction — 25 reports (5.12%)
  7. Epistaxis — 23 reports (4.71%)
  8. Fall — 23 reports (4.71%)
  9. Pain — 23 reports (4.71%)
  10. Contusion — 22 reports (4.51%)

Source database →

Other Hematology approved in United States

Frequently asked questions

Is Coagulation Factor VIII approved in United States?

Coagulation Factor VIII does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Coagulation Factor VIII in United States?

Beijing Children's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.